Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,455,737
+$88,378 QoQ
Shares Held
5,785
-8.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2,200
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. ABBV ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,074 | $1,475,276 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
5,785 | $1,455,737 | |
| 3 | JNJ |
Johnson & Johnson
|
4,993 | $1,268,072 | |
| 4 | LLY |
ELI LILLY & Co
|
768 | $921,162 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,878 | $626,823 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
744 | $93,996 | |
| 7 | NVO |
Novo Nordisk A S
|
1,841 | $88,257 | |
| 8 | PFE |
Pfizer Inc
|
881 | $21,214 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,455,737 | 5,785 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,367,359 | 6,287 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,436,516 | 6,287 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,385,766 | 5,985 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,110,935 | 5,985 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1,253,977 | 5,985 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,064,245 | 5,989 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,228,523 | 6,221 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,121,054 | 6,536 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,190,205 | 6,536 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,014,433 | 6,546 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $976,790 | 6,553 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $882,885 | 6,553 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,020,127 | 6,401 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,025,415 | 6,345 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $818,545 | 6,099 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $949,438 | 6,199 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,004,918 | 6,199 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,286,164 | 9,499 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $863,930 | 8,009 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $812,021 | 7,209 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $758,513 | 7,009 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,421,022 | 13,262 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,170,201 | 13,360 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,322,582 | 13,471 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,026,050 | 13,467 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||